Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Brouwers

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Crohn'S & Colitis|January 8, 2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative ColitisIris Detrez, Erwin Dreesen, Thomas Van Stappen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Development of a genotype 325-specific proCPU/TAFI ELISAAnn Gils, Marie-Christine Alessi, Els Brouwers, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 23, 2016
Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assaysSumin Bian, Thomas Van Stappen, Filip Baert, et al.
Therapeutic Drug Monitoring|June 7, 2014
Development of a universal anti-adalimumab antibody standard for interlaboratory harmonizationAnn Gils, Niels Vande Casteele, Raf Poppe, et al.
Plos One|May 4, 2018
Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasminShiraazkhan Abdul, Miet Peeters, Els Brouwers, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed labelSebastian Stefanovic, Iris Detrez, Griet Compernolle, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Crohn'S & Colitis|January 8, 2016
Variability in Golimumab Exposure: A 'Real-Life' Observational Study in Active Ulcerative ColitisIris Detrez, Erwin Dreesen, Thomas Van Stappen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 6, 2003
Development of a genotype 325-specific proCPU/TAFI ELISAAnn Gils, Marie-Christine Alessi, Els Brouwers, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 23, 2016
Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assaysSumin Bian, Thomas Van Stappen, Filip Baert, et al.
Therapeutic Drug Monitoring|June 7, 2014
Development of a universal anti-adalimumab antibody standard for interlaboratory harmonizationAnn Gils, Niels Vande Casteele, Raf Poppe, et al.
Plos One|May 4, 2018
Generation and characterization of monoclonal antibodies against the N-terminus of alpha-2-antiplasminShiraazkhan Abdul, Miet Peeters, Els Brouwers, et al.
European Journal of Gastroenterology & Hepatology|August 18, 2020
Endoscopic remission can be predicted by golimumab concentrations in patients with ulcerative colitis treated with the changed labelSebastian Stefanovic, Iris Detrez, Griet Compernolle, et al.
Pageof 2